Skip to content
OpenCapital
Get started

Senti Biosciences SNTI Q1 2026 Annual earnings

Reported May 14, 2026 · Before market open

Revenue$16.0K
EPS-$0.36Miss by $0.09
EPS estimate-$0.27

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$14.9K
EPS estimate-$0.33

Versus estimates

Revenue

Q1 2026$16.0K
Q4 2025$22.0KMiss by $978.0KQ4 2024$5.9MBeat by $3.1M

Diluted EPS

Q1 2026-$0.36Miss by $0.09
Q4 2025-$0.38Beat by $0.05Q3 2025-$0.69Miss by $0.10Q2 2025-$0.56Beat by $0.34Q1 2025-$1.41Miss by $0.83Q4 2024-$0.67Beat by $2.46

Ask the moment Senti Biosciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Senti Biosciences report Q1 2026 earnings?
Senti Biosciences (SNTI) reported Q1 2026 earnings on May 14, 2026 before market open.
What were Senti Biosciences's Q1 2026 revenue and EPS?
Senti Biosciences reported revenue of $16.0K and eps of $-0.36 for Q1 2026.
Did Senti Biosciences beat estimates in Q1 2026?
EPS missed the consensus estimate of $-0.27 by $0.09.
How did Senti Biosciences's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 74.5% from $-1.41.
Where can I find Senti Biosciences's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-034834) and the 10-K/A periodic report (0001628280-26-028429) directly on SEC EDGAR. The filing index links above go to sec.gov.